Mitsuro Kanda

46PUBLICATIONS
68CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)SurgeryMolecular targetsPacific Peoples diet and nutrition
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (46)

|Aug 18, 2026
BBS5 as a robust prognostic biomarker in esophageal squamous cell carcinoma: validation in two independent cohorts.

|Aug 03, 2026
Oligometastatic esophageal squamous cell carcinoma: a systematic review of current definitions and meta-analysis of local therapy outcomes.

|Jul 03, 2026
Real-World Data of Retroperitoneal Tumor Surgeries Performed by Gastroenterological Surgeons in Japan: Analysis Based on the National Clinical Database.

|Dec 08, 2025
Phase II study of FOLFIRI with low-dose irinotecan plus ramucirumab as second-line treatment in Japanese patients with metastatic colorectal cancer (study rindo).

Norifumi Hattori, Goro Nakayama, Shinichi Umeda

|Sep 22, 2025
Adverse events of postoperative adjuvant chemotherapy predict survival outcomes in locally advanced colorectal cancer: a pooled analysis of Japanese clinical trials.

Hidetaka Kawamura, Michitaka Honda, Yujiro Nakayama

|Aug 05, 2025
Overexpression of cat eye syndrome chromosome region, candidate 2 in esophageal squamous carcinoma cell promotes tumor aggressiveness by facilitating NF-κB signaling and inhibition of p53-associated apoptosis.

Haote Zhu, Mitsuro Kanda, Dai Shimizu

Pageof 8

Frequent Collaborators

7 joint publications

Yasuhiro Kodera

4 joint publications

Dai Shimizu

3 joint publications

Suguru Yamada

3 joint publications

Masamichi Hayashi